Kennedy Raymond E, Corsi Taylor, Ventarola Daniel J, Rahimi Saum A, Beckerman William E
Division of Vascular Surgery and Endovascular Therapy, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Rutgers Robert Wood Johnson Medical School, Piscataway, NJ.
J Vasc Surg Cases Innov Tech. 2021 Feb 9;7(2):226-229. doi: 10.1016/j.jvscit.2021.01.002. eCollection 2021 Jun.
AngioJet rheolytic thrombectomy, although a successful treatment modality for arterial thrombus removal and recanalization, has been shown to have increased rates of postoperative acute kidney injury (AKI) compared with other methods of treatment for acute limb ischemia. The postinterventional course of AKI can differ markedly from patient to patient, but typically resolves relatively quickly. Herein, we present a case of AKI secondary to AngioJet intervention that demonstrates an exceedingly prolonged but ultimately recoverable course with conservative management and without the need for renal replacement therapy.
AngioJet 流变血栓切除术虽然是一种成功的动脉血栓清除和再通治疗方式，但与其他急性肢体缺血治疗方法相比，已显示术后急性肾损伤（AKI）发生率更高。AKI 的介入后病程在患者之间可能有显著差异，但通常恢复相对较快。在此，我们报告一例因 AngioJet 介入导致的 AKI 病例，该病例显示病程极长，但通过保守治疗最终可恢复，且无需肾脏替代治疗。
